US Patent Issued to ACESIS BIOMED US on June 10 for "Testosterone-inducing peptide compounds and associated combinations" (Canadian, American Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,839, issued on June 10, was assigned to ACESIS BIOMED US INC. (Centennial, Colo.).

"Testosterone-inducing peptide compounds and associated combinations" was invented by Vassilios Papadopoulos (Pasadena, Calif.) and Daniel Benjamin Martinez-Arguelles (Ottawa).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure concerns peptide compounds of formula I or II and combinations thereof that can be administered orally for promoting endogenous steroid, and particularly testosterone, production:(I)A-Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-B (II)A-Xaa1-XaaA-XaaB-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-XaaC-XaaD-XaaE-Xaa8-B."

The patent was filed on Nov...